Johnson & Johnson will go head-to-head in the US neurovascular market against Medtronic PLC and Stryker Corp. with its EmboTrap clot retrieval device, after US FDA gave the product the thumbs-up.
J&J's EmboTrap Clot Retriever Gets US Green Light
Johnson & Johnson has added the Embotrap clot retrieval device to its US offering after the product got FDA clearance. It will compete with Medtronic's Solitaire and Stryker's Trevo, which are already on the US market.